Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

GABAergic neurons in nucleus accumbens are correlated to resilience and vulnerability to chronic stress for major depression.

Zhu Z, Wang G, Ma K, Cui S, Wang JH.

Oncotarget. 2017 May 30;8(22):35933-35945. doi: 10.18632/oncotarget.16411.

2.

Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state.

Fuchs T, Jefferson SJ, Hooper A, Yee PH, Maguire J, Luscher B.

Mol Psychiatry. 2017 Jun;22(6):920-930. doi: 10.1038/mp.2016.188. Epub 2016 Nov 8.

3.

Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress.

Ma K, Xu A, Cui S, Sun MR, Xue YC, Wang JH.

Transl Psychiatry. 2016 Oct 4;6(10):e910. doi: 10.1038/tp.2016.181.

4.

GABA+ levels in postmenopausal women with mild-to-moderate depression: A preliminary study.

Wang Z, Zhang A, Zhao B, Gan J, Wang G, Gao F, Liu B, Gong T, Liu W, Edden RA.

Medicine (Baltimore). 2016 Sep;95(39):e4918. doi: 10.1097/MD.0000000000004918.

5.

Fully automated macromolecule suppressed single voxel glutamate spectroscopy (FAMOUS SVGS).

Nanga RP, Hariharan H, Reddy R.

J Transl Med. 2016 Jul 26;14(1):220. doi: 10.1186/s12967-016-0970-1.

6.

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.

Lener MS, Niciu MJ, Ballard ED, Park M, Park LT, Nugent AC, Zarate CA Jr.

Biol Psychiatry. 2017 May 15;81(10):886-897. doi: 10.1016/j.biopsych.2016.05.005. Epub 2016 May 12. Review.

PMID:
27449797
7.

Molecular Mechanism for Stress-Induced Depression Assessed by Sequencing miRNA and mRNA in Medial Prefrontal Cortex.

Ma K, Guo L, Xu A, Cui S, Wang JH.

PLoS One. 2016 Jul 18;11(7):e0159093. doi: 10.1371/journal.pone.0159093. eCollection 2016.

8.

GABA System in Schizophrenia and Mood Disorders: A Mini Review on Third-Generation Imaging Studies.

Chiapponi C, Piras F, Piras F, Caltagirone C, Spalletta G.

Front Psychiatry. 2016 Apr 19;7:61. doi: 10.3389/fpsyt.2016.00061. eCollection 2016. Review.

9.

Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.

Ren Z, Pribiag H, Jefferson SJ, Shorey M, Fuchs T, Stellwagen D, Luscher B.

Biol Psychiatry. 2016 Sep 15;80(6):457-68. doi: 10.1016/j.biopsych.2016.02.009. Epub 2016 Feb 13.

10.

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.

Dubin MJ, Mao X, Banerjee S, Goodman Z, Lapidus KA, Kang G, Liston C, Shungu DC.

J Psychiatry Neurosci. 2016 Apr;41(3):E37-45.

11.

Incoordination among Subcellular Compartments Is Associated with Depression-Like Behavior Induced by Chronic Mild Stress.

Xu A, Cui S, Wang JH.

Int J Neuropsychopharmacol. 2016 Apr 29;19(5). pii: pyv122. doi: 10.1093/ijnp/pyv122. Print 2016 May.

12.

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, Mao X, Rodriguez CI, Oquendo MA, Suckow RF, Cooper TB, Keilp JG, Shungu DC, Mann JJ.

Mol Psychiatry. 2016 Mar;21(3):320-7. doi: 10.1038/mp.2015.83. Epub 2015 Aug 18.

13.

Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder.

Abdallah CG, Jackowski A, Sato JR, Mao X, Kang G, Cheema R, Coplan JD, Mathew SJ, Shungu DC.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1082-90. doi: 10.1016/j.euroneuro.2015.04.025. Epub 2015 May 5.

14.
15.

In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.

DeLorenzo C, DellaGioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, Yang J, Wen R, Mann JJ, Krystal JH, Parsey RV, Carson RE, Esterlis I.

Biol Psychiatry. 2015 Feb 1;77(3):266-75. doi: 10.1016/j.biopsych.2014.06.024. Epub 2014 Jul 10.

16.

Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.

Abdallah CG, Niciu MJ, Fenton LR, Fasula MK, Jiang L, Black A, Rothman DL, Mason GF, Sanacora G.

Psychother Psychosom. 2014;83(5):298-307. doi: 10.1159/000361078. Epub 2014 Aug 6.

17.

Neurochemistry of major depression: a study using magnetic resonance spectroscopy.

Godlewska BR, Near J, Cowen PJ.

Psychopharmacology (Berl). 2015 Feb;232(3):501-7. doi: 10.1007/s00213-014-3687-y. Epub 2014 Jul 31.

18.

Glutamate metabolism in major depressive disorder.

Abdallah CG, Jiang L, De Feyter HM, Fasula M, Krystal JH, Rothman DL, Mason GF, Sanacora G.

Am J Psychiatry. 2014 Dec 1;171(12):1320-7. doi: 10.1176/appi.ajp.2014.14010067. Epub 2014 Oct 31.

19.

Treatment-resistant depression in primary care across Canada.

Rizvi SJ, Grima E, Tan M, Rotzinger S, Lin P, Mcintyre RS, Kennedy SH.

Can J Psychiatry. 2014 Jul;59(7):349-57.

20.

Disturbance of the glutamatergic system in mood disorders.

Jun C, Choi Y, Lim SM, Bae S, Hong YS, Kim JE, Lyoo IK.

Exp Neurobiol. 2014 Mar;23(1):28-35. doi: 10.5607/en.2014.23.1.28. Epub 2014 Mar 27. Review.

Supplemental Content

Support Center